Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Date	Time	Source	Headline	Symbol	Company
06/22/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces departure of CSO Piet Wigerinck later this year	EU:GLPG	Galapagos
06/22/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces departure of CSO Piet Wigerinck later this year	EU:GLPG	Galapagos
06/07/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
06/07/2021	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
06/04/2021	1:01AM	GlobeNewswire Inc.	SELECTION study on filgotinib in ulcerative colitis published in The Lancet	EU:GLPG	Galapagos
06/04/2021	1:01AM	GlobeNewswire Inc.	SELECTION study on filgotinib in ulcerative colitis published in The Lancet	EU:GLPG	Galapagos
05/27/2021	4:01PM	GlobeNewswire Inc.	Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress	EU:GLPG	Galapagos
05/27/2021	4:01PM	GlobeNewswire Inc.	Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress	EU:GLPG	Galapagos
05/18/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness...	EU:GLPG	Galapagos
05/18/2021	4:01PM	GlobeNewswire Inc.	Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness...	EU:GLPG	Galapagos
05/06/2021	4:01PM	GlobeNewswire Inc.	Galapagos refocuses pipeline and rightsizes operations	EU:GLPG	Galapagos
05/06/2021	4:01PM	GlobeNewswire Inc.	Galapagos refocuses pipeline and rightsizes operations	EU:GLPG	Galapagos
05/04/2021	4:01PM	GlobeNewswire Inc.	Transparency notification received from The Capital Group	EU:GLPG	Galapagos
05/04/2021	4:01PM	GlobeNewswire Inc.	Transparency notification received from The Capital Group	EU:GLPG	Galapagos
04/30/2021	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plans	EU:GLPG	Galapagos
04/30/2021	4:01PM	GlobeNewswire Inc.	Galapagos creates new subscription right plans	EU:GLPG	Galapagos
04/23/2021	3:23AM	Dow Jones News	e-Therapeutics Expects to Receive Payments From Galapagos	EU:GLPG	Galapagos
04/23/2021	12:01AM	GlobeNewswire Inc.	Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequa...	EU:GLPG	Galapagos
04/23/2021	12:01AM	GlobeNewswire Inc.	Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequa...	EU:GLPG	Galapagos
04/08/2021	4:01PM	GlobeNewswire Inc.	Extension of lock-up period in Gilead-Galapagos collaboration agreement	EU:GLPG	Galapagos
04/08/2021	4:01PM	GlobeNewswire Inc.	Extension of lock-up period in Gilead-Galapagos collaboration agreement	EU:GLPG	Galapagos
03/25/2021	4:01PM	GlobeNewswire Inc.	Publication of the annual report and invitation to the ordinary shareholders’ meeting	EU:GLPG	Galapagos
03/25/2021	4:01PM	GlobeNewswire Inc.	Publication of the annual report and invitation to the ordinary shareholders’ meeting	EU:GLPG	Galapagos
03/24/2021	4:01PM	GlobeNewswire Inc.	Galapagos appoints Bart Filius as President and Chief Operating Officer	EU:GLPG	Galapagos
03/24/2021	4:01PM	GlobeNewswire Inc.	Galapagos appoints Bart Filius as President and Chief Operating Officer	EU:GLPG	Galapagos
03/19/2021	5:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
03/19/2021	5:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
03/04/2021	1:49AM	GlobeNewswire Inc.	GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES	EU:GLPG	Galapagos
03/04/2021	1:49AM	GlobeNewswire Inc.	GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES	EU:GLPG	Galapagos
03/03/2021	4:15PM	GlobeNewswire Inc.	Transparency notification received from The Capital Group	EU:GLPG	Galapagos

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Brookmount Explorations (PK)

Ubiquitech Software (PK)

NioCorp Developments

Anavex Life Sciences

Decentral Life (PK)

Fannie Mae (QB)

Seven Arts Entertainment (PK)

Delayed Upgrade Clock